-
March 2008: Higher Doses Of Celebrex Are Associated With Heart Attack And Stroke Risks
Lower, More Popular Dose Presumed To Be Safe, But Definitive Study Results Will Not Be Available For Few More Years (Posted by Tom Lamb at DrugInjuryWatch.com) On March 31, 2008, at the American College…
-
New Article With 25 Big Pharma Facts, And Free Online Tool To Search MedWatch Report Data
A Couple Of Recent Offerings From Our Readers, For Your Consideration (Posted by Tom Lamb at DrugInjuryWatch.com) As you will see, we have two readers who emailed me recently to thank for today’s post.…
-
Zyprexa And Diabetes: Is This A Tale Of Company Greed Coupled With FDA Failure?
Alaska v. Eli Lilly Trial: Focus Is On What Was Known About This Alleged Side Effect, And When They Knew It (Posted by Tom Lamb at DrugInjuryWatch.com) News reports about the case Alaska v.…
-
More Information About Reports Of Byetta Use Being Linked To Acute Pancreatitis
March 2008 Article In FDA's Drug Safety Newsletter Discusses Two Cases In Detail (Posted by Tom Lamb at DrugInjuryWatch.com) The quarterly issue of the FDA's online Drug Safety Newsletter [DSN] which was published on…
-
Issue: Should We Be Prohibited From Filing Product Liability Lawsuits Against Medical Device Manufacturers And Pharmaceutical Companies?
Opinion: Patient Lawsuits Are A Significant Incentive For These Manufacturers And Companies To Ensure That Their Products Are Safe For Use By American Patients (Posted by Tom Lamb at DrugInjuryWatch.com) First of all, I…
-
Tequin Revisited: Health Canada And The FDA Failed To Take Action, At Our Expense
Bristol-Myers Squibb Was Allowed To Withdraw Their Unsafe Drug For "Economic Reasons", And Only After Selling Off Its Inventory (Posted by Tom Lamb at DrugInjuryWatch.com) An article by Joel Lexchin, MSc MD, "Information about…
